Document type
Clinical pathways
Place
Hertfordshire and West Essex ICB
Output type
Clinical Pathways
Pathway
PSA Pathway

PSA Pathway

Pathway published: June 2024
Next review date: June 2026 
 
 
Patient request a PSA test

Consider appropriateness of the test, including:
• Life expectancy
• Age
• Family history of prostate cancer
• Risk factors for prostate cancer, including: black ethnic origin, family history of prostate cancer, increasing age, germline mutations (HOXB13, BRCA1/2).
• Previous diagnosis of prostate cancer 
 
Note PSA results should be doubled for interpretation if patient on 5-alpha reductase inhibitor (finasteride / dutasteride)

For asymptomatic men with a life expectancy of less than 10 years, PSA testing is not recommended as it is unlikely to benefit them, unless requested by a urologist 
 
Please see pathway attached for further information. 
Back